Inhibikase Therapeutics News

Inhibikase Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 15 16:14 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Werner Milton H.

Apr 3 16:51 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lees-Rolfe Garth

Apr 2 17:17 ET

Inhibikase Therapeutics | 8-K/A: Current report (Amendment)

Apr 2 17:17 ET

Inhibikase Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Lees-Rolfe Garth

Apr 2 17:17 ET

Inhibikase Therapeutics | 10-K: Annual report

Mar 27 16:12 ET

Inhibikase Therapeutics | 8-K: Current report

Feb 7 08:01 ET

Inhibikase Therapeutics | 424B5: Prospectus

Feb 1 16:54 ET

Inhibikase Therapeutics | 8-K: Current report

Feb 1 16:14 ET

Inhibikase Therapeutics | 8-K: Current report

Jan 16 00:00 ET

Inhibikase Therapeutics: Q3 2023 Earnings Report

Nov 14, 2023 16:15 ET

Inhibikase Therapeutics | 10-K/A: Annual report (Amendment)

Oct 16, 2023 17:24 ET

Inhibikase Therapeutics | 8-K: Current report

Sep 20, 2023 11:23 ET

Inhibikase Therapeutics | 10-Q: Q2 2023 Earnings Report

Aug 14, 2023 16:07 ET

Inhibikase Therapeutics | 8-K: Current report

Jul 17, 2023 17:29 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BERMAN DENNIS N

Jul 5, 2023 21:18 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dion Gisele

Jul 5, 2023 21:16 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GRINT PAUL C

Jul 5, 2023 21:12 ET

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Freeman Roy Lester

Jul 5, 2023 21:11 ET

Inhibikase Therapeutics | 8-K: Current report

Jun 29, 2023 12:15 ET